Sanofi SNY has announced that the FDA has granted a fast-track designation to its one-time intravitreal gene therapy, SAR446597, for the treatment of geographic atrophy (GA) due to age-related macular ...

Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a clinical ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The eye test would be another tool for early diagnosis of degenerative brain diseases. A blood test that assists with early ...

These are exciting times for biotech business Complement Therapeutics, which stands on the cusp of an important milestone in ...